To analyse the degree of trust placed in sources of medical information by practising doctors-therapists. METHODS: We questioned 144 doctors or therapists from various cities in Central Russia. Doctors completed a questionnaire containing demographic data, information sources and how much trust they placed in these sources. RESULTS: Mean age of respondents was 43.4 [SD 9.8] years with 60% women and 40% men. Most (92%) noted that their basic sources of specialised information were various medical magazines. In daily work, 84% use various directories and consult with colleagues. Doctors use books and other monographs in 55% of cases and 49.3% receive information from medical representatives of companies. Just over a quarter (29% and 26%) receive information from advanced training courses and from weekly hospital meetings. Only 1.7% of doctors use specialized medical Internet sites. The most important criteria for quality information were availability and reliability of data. The most trustworthy information, in the opinion of practising doctors, was from medical magazines (78%) and information from courses to upgrade qualifications (60%). CONCLUSION: Our data reflect the need to implement measures to improve the quality of medical information.
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SOURCES OF MEDICAL INFORMATION AND DEGREE OF TRUST PLACED IN THEM BY RUSSIAN DOCTORS
Zaytsev A State Institute for Advanced Training of Physicians, Ministry of Defense, Moscow, Russia OBJECTIVE: To analyse the degree of trust placed in sources of medical information by practising doctors-therapists. METHODS: We questioned 144 doctors or therapists from various cities in Central Russia. Doctors completed a questionnaire containing demographic data, information sources and how much trust they placed in these sources. RESULTS: Mean age of respondents was 43.4 [SD 9 .8] years with 60% women and 40% men. Most (92%) noted that their basic sources of specialised information were various medical magazines. In daily work, 84% use various directories and consult with colleagues. Doctors use books and other monographs in 55% of cases and 49.3% receive information from medical representatives of companies. Just over a quarter (29% and 26%) receive information from advanced training courses and from weekly hospital meetings. Only 1.7% of doctors use specialized medical Internet sites. The most important criteria for quality information were availability and reliability of data. The most trustworthy information, in the opinion of practising doctors, was from medical magazines (78%) and information from courses to upgrade qualifications (60%). CONCLUSION: Our data reflect the need to implement measures to improve the quality of medical information.
PHP45 COMMON DRUG REVIEW (CDR) RECOMMENDATIONS: DOES COST-EFFECTIVENESS MATTER?
Rocchi A, Miller B Axia Research, Hamilton, ON, Canada OBJECTIVE: CDR is the Canadian central review agency whose advisory body, the Canadian Expert Drug Advisory Committee (CEDAC), makes recommendations for drug reimbursement decisions by public payers. CEDAC is explicitly charged to consider cost-effectiveness in its mandate. A review was conducted of all Reasons for Recommendation to determine if and how costeffectiveness information was used. METHODS: Reasons for Recommendation were identified from the CDR website, from inception (September 2003) to the end of October 2007. Reasons were reviewed by both authors. Each drug indication was categorized as follows: cost-effectiveness was mentioned in the Reasons, incremental cost-effectiveness ratios (ICERs) were considered attractive, and the listing recommendation. ICERs were designated as attractive or not based on either direct comments in the Reasons or indirectly through the restrictiveness of the recommended criteria. Descriptive statistics were performed. RESULTS: There were recommendations for 78 unique drug submissions. Economic evidence was not mentioned in 55% of recommendations (N = 44). Costeffectiveness was mentioned in the remaining 45% of recommendations (N = 34). The ICER was considered attractive for 15% of drugs (N = 5), with an ICER range from dominant (N = 3) to $71K/life year gained. These five drugs had positive listing recommendations. Drugs that were economically unattractive but achieved positive recommendations had an ICER range (where stated) from $50K-$80K/QALY. Economically unattractive drugs with negative recommendations had an ICER range from $18K to $189K/QALY. CONCLUSION: Cost-effectiveness was often not mentioned in CEDAC recommendations. There appeared to be an acceptability threshold of $50K/QALY with a grey zone extending up to $80K/QALY. However, many drugs were not recommended which had ICERs below these thresholds. Overall, economic information had a limited role for informing Canadian drug reimbursement recommendations. To study the impact of a model adopted to improve availability and accessibility to essential drugs and impact on hospital budget in a super specialty tertiary care hospital. METHODS: The interventions consisted of selection of limited list of essential medicines (EML) and procurement through centralized pooled procurement system in 1996-1997, followed by setting up of Drugs & Therapeutic Committee (DTC) to review drug expenditure and prescribing pattern in 1998. Analysis of the annual hospital budget, expenditure on drugs, availability of key drugs, stock-outs, and ABC analysis was done before (1994) (1995) (1996) and after intervention (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) . RESULTS: Rise in average drug expenditure from 3.63% to 5.16% only was observed after intervention despite 5-fold rise in patient attendance. Previous trend of ever rising annual drug expenditure was reversed immediately after interventions in 1997 as drug expenditure reduced by 47%, accompanied by increased availability (94.6%) of key drugs. Despite high expenditure on key drugs (75.89%) mean availability was 67.48% but after intervention with the same expenditure (77.68%) it increased to 95.28%. Percent drugs out-of-stock decreased from 27.57% to 19.57% & were of minor duration with no stock-out of vital drugs. ABC analysis before intervention showed only 3.33 drugs of the category A consumed 74% budget which increased to 9.63 drugs consuming 79.53% of the annual drug budget. Analysis of top 10 drugs consumed showed reversal of previous trend of non-essential among top 10 drugs from 1998 onwards where only vital drugs represented top 10 drugs. CON-CLUSION: Effective containment of overall expenditure on drugs accompanied by increased availability of essential drugs is possible by some managerial interventions-selection of essential drugs, centralized pooled procurement and functioning DTC. These interventions serve to optimize the value of limited government funds and thereby empower and support government in making basic medicines available to all.
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